Jonathan I Lieber - Net Worth and Insider Trading
Jonathan I Lieber Net Worth
The estimated net worth of Jonathan I Lieber is at least $862 dollars as of 2024-05-06. Jonathan I Lieber is the Director of Salarius Pharmaceuticals Inc and owns about 1,500 shares of Salarius Pharmaceuticals Inc (SLRX) stock worth over $752. Jonathan I Lieber is also the CFO of Ocugen Inc and owns about 83 shares of Ocugen Inc (OCGN) stock worth over $110. Details can be seen in Jonathan I Lieber's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jonathan I Lieber has not made any transactions after 2022-06-07 and currently still holds the listed stock(s).
Transaction Summary of Jonathan I Lieber
Jonathan I Lieber Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jonathan I Lieber owns 6 companies in total, including Checkmate Pharmaceuticals Inc (CMPI) , Salarius Pharmaceuticals Inc (SLRX) , and Ocugen Inc (OCGN) among others .
Click here to see the complete history of Jonathan I Lieber’s form 4 insider trades.
Insider Ownership Summary of Jonathan I Lieber
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CMPI | Checkmate Pharmaceuticals Inc | 2020-08-06 | See Remarks |
SLRX | Salarius Pharmaceuticals Inc | 2022-06-07 | director |
OCGN | Ocugen Inc | 2016-12-02 | Chief Financial Officer |
2012-09-20 | CFO | ||
2022-08-21 | Chief Financial Officer | ||
2023-02-01 | See Remarks |
Jonathan I Lieber Latest Holdings Summary
Jonathan I Lieber currently owns a total of 2 stocks. Among these stocks, Jonathan I Lieber owns 1,500 shares of Salarius Pharmaceuticals Inc (SLRX) as of June 7, 2022, with a value of $752 and a weighting of 87.19%. Jonathan I Lieber also owns 83 shares of Ocugen Inc (OCGN) as of December 2, 2016, with a value of $110 and a weighting of 12.81%.
Latest Holdings of Jonathan I Lieber
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SLRX | Salarius Pharmaceuticals Inc | 2022-06-07 | 1,500 | 0.50 | 752 |
OCGN | Ocugen Inc | 2016-12-02 | 83 | 1.33 | 110 |
Holding Weightings of Jonathan I Lieber
Jonathan I Lieber Form 4 Trading Tracker
According to the SEC Form 4 filings, Jonathan I Lieber has made a total of 1 transactions in Salarius Pharmaceuticals Inc (SLRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Salarius Pharmaceuticals Inc is the acquisition of 1,500 shares on June 7, 2022, which cost Jonathan I Lieber around $7,125.
According to the SEC Form 4 filings, Jonathan I Lieber has made a total of 0 transactions in Ocugen Inc (OCGN) over the past 5 years. The most-recent trade in Ocugen Inc is the acquisition of 83 shares on December 2, 2016, which cost Jonathan I Lieber around $9,750.
Insider Trading History of Jonathan I Lieber
- 1
Jonathan I Lieber Trading Performance
GuruFocus tracks the stock performance after each of Jonathan I Lieber's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jonathan I Lieber is -2.46%. GuruFocus also compares Jonathan I Lieber's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jonathan I Lieber within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jonathan I Lieber's insider trading performs compared to the benchmark.
Performance of Jonathan I Lieber
Jonathan I Lieber Ownership Network
Ownership Network List of Jonathan I Lieber
Ownership Network Relation of Jonathan I Lieber
Jonathan I Lieber Owned Company Details
What does Checkmate Pharmaceuticals Inc do?
Who are the key executives at Checkmate Pharmaceuticals Inc?
Jonathan I Lieber is the See Remarks of Checkmate Pharmaceuticals Inc. Other key executives at Checkmate Pharmaceuticals Inc include 10 percent owner Venbio Global Strategic Fund Ii L.p. , director & Chief Executive Officer Alan Bash , and 10 percent owner Novo Holdings A/s .
Checkmate Pharmaceuticals Inc (CMPI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Checkmate Pharmaceuticals Inc (CMPI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Checkmate Pharmaceuticals Inc (CMPI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Checkmate Pharmaceuticals Inc (CMPI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Checkmate Pharmaceuticals Inc Insider Transactions
Jonathan I Lieber Mailing Address
Above is the net worth, insider trading, and ownership report for Jonathan I Lieber. You might contact Jonathan I Lieber via mailing address: C/o Histogenics Corporation, 830 Winter Street #3, Waltham Ma 02451.